BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Harvard Global Health Institute - ECPv6.5.1.4//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://globalhealth.harvard.edu
X-WR-CALDESC:Events for Harvard Global Health Institute
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20260101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=UTC:20260416T090000
DTEND;TZID=UTC:20260416T160000
DTSTAMP:20260525T103325
CREATED:20260128T200202Z
LAST-MODIFIED:20260128T200404Z
UID:10001048-1776330000-1776355200@globalhealth.harvard.edu
SUMMARY:2026 Global Health Symposium
DESCRIPTION:  \nJoin the Harvard Global Health Institute (HGHI) for its 4th Annual Global Health Symposium\, Global Health Forward: Strength Through Innovation and Collective Action. This hybrid event convenes experts from Harvard and around the world to examine pressing global health challenges and explore innovative\, collaborative solutions. \nDate: Thursday\, April 16\, 2026 \nTime: 9:00am – 4:00pm Eastern Time (ET) \nDesigned for students\, faculty\, practitioners\, policymakers\, and global health leaders\, the symposium features keynote remarks\, expert-led discussions\, and panels addressing issues such as global health governance\, emergency preparedness\, and the global health workforce. \nThe 2026 symposium will feature a keynote address by Dr. Sania Nishtar\, CEO of Gavi\, the Vaccine Alliance\, whose leadership has advanced vaccine equity\, strengthened health systems\, and fostered global cooperation in health. \nAdditional details\, including the full agenda and speaker list\, to be shared on the 2026 Symposium page as they become available. \nFormat & Registration\nThe symposium will be held in a hybrid format and livestreamed worldwide. The event is free and open to the public; in-person attendance is by invitation only. \nRegister
URL:https://globalhealth.harvard.edu/event/event-2026-global-health-symposium/
LOCATION:Livestream
ATTACH;FMTTYPE=image/png:https://globalhealth.harvard.edu/wp-content/uploads/2025/12/2026-Symposium-Theme_Square-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20260417T093000
DTEND;TZID=UTC:20260417T113000
DTSTAMP:20260525T103325
CREATED:20260128T201916Z
LAST-MODIFIED:20260303T210214Z
UID:10001049-1776418200-1776425400@globalhealth.harvard.edu
SUMMARY:2026 Harvard Global Health Student Research Showcase
DESCRIPTION:We invite you to join us at the 2026 Harvard Global Health Student Research Showcase\, a university-wide poster session highlighting global health research conducted by Harvard undergraduate and graduate students. We encourage members of the Harvard community to join us to view posters\, learn about ongoing research across the University\, and support student scholarship. \nThe Harvard Global Health Student Research Showcase celebrates student research and promotes interdisciplinary exchange\, bringing together perspectives from research\, practice\, and policy across Harvard. The event provides an opportunity to engage with emerging work on pressing global health challenges and to foster dialogue and collaboration across disciplines and sectors. \nDate: Friday\, April 17\, 2026Time: 9:30am – 11:30am ETLocation: Kresge Cafeteria\, Harvard T.H. Chan School of Public Health \nOpen to current all members of the Harvard community with an HUID. Registration is not required\, but strongly encouraged. Walk-ins are welcome. \nThis event is held in partnership with the Department of Global Health and Population at the Harvard T.H. Chan School of Public Health. \nRegister
URL:https://globalhealth.harvard.edu/event/event-harvard-global-health-student-research-showcase/
LOCATION:Harvard T.H. Chan School of Public Health\, 677 Huntington Avenue\, Boston\, MA\, 02115\, United States
CATEGORIES:In-person
ATTACH;FMTTYPE=image/png:https://globalhealth.harvard.edu/wp-content/uploads/2026/01/Call-for-Abstracts-HGHIs-2026-Student-Research-Showcase-900x600-1-5-e1769631209389.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20260424T090000
DTEND;TZID=UTC:20260424T100000
DTSTAMP:20260525T103325
CREATED:20260408T210503Z
LAST-MODIFIED:20260409T201436Z
UID:10001055-1777021200-1777024800@globalhealth.harvard.edu
SUMMARY:Measuring Impact: How Do We Know AI Is Improving Health Outcomes and Addressing Local Priorities in Global Health?
DESCRIPTION:As artificial intelligence becomes increasingly embedded in health systems\, how can we know whether these tools are delivering meaningful health benefits? AI tools can be updated and redeployed faster than the evidence validating them\, raising the question of whether current evaluation frameworks are built for the speed of adoption. \nThis session explores what rigorous impact assessments for AI tools should address. Key questions include: How do we comprehensively evaluate whether these tools deliver meaningful health benefits? How should we think about data ownership\, accountability\, and sovereignty? How can we design evaluation frameworks that are both locally relevant and rigorously sound? The conversation will connect these frameworks to the broader needs of health systems. We will discuss how governments and donors can leverage evaluations to make evidence-based decisions and embed accountability into the scale-up process. \nHosted by the Harvard Global Health Institute and co-organized by the Center for Bioethics at Harvard Medical School. \nThis webinar is free and open to the public and will conclude with a live Q&A session. \nRegister \n  \nSpeakers\n \nJude Kong\, B.Ed.\, B.Sc.\, M.Sc.\, Ph.D.\, CRC\, MRSC   \nExecutive Director\, Artificial Intelligence and Mathematical Modelling Lab (AIMM Lab)\, University of Toronto\nExecutive Director\, Global South AI for Pandemic and Epidemic Preparedness and Response Network (AI4PEP) \nProf. Kong\, Canada Research Chair in Community-Oriented AI and Mathematical Modeling at the University of Toronto and member of the College of the Royal Society of Canada (RSC)\, pioneers equitable\, mathematical and AI-driven solutions for global health crises. He founded and directs AI4PEP\, ACADIC\, AIMMLab\, and REASURE2\, advancing community-led innovation across the Global South and Canada. With 201+ publications and multiple awards\, including the 2025 DLSPH’s Excellence in Research\, he shapes health policy\, empowers underrepresented STEM scholars\, and drives inclusive\, Southern-led scientific collaboration. \n  \n \nChaitali Sinha\, M.A. \nSenior Program Specialist at International Development Research Centre (IDRC) \nChaitali Sinha is a Senior Program Specialist in the Global Health Division at Canada’s International Development Research Centre (IDRC). She has over 20 years of experience with research for development in Africa\, Asia\, Latin America and the Caribbean\, and the Middle East\, with a focus on global health\, sexual and reproductive health\, and rights\, health information systems\, refugee health\, feminist research and gender analysis\, and digital innovation. Chaitali has published peer-reviewed articles\, book chapters\, and blogs on issues of gender and digital health\, health equity\, gender transformative research\, and health systems strengthening. She holds a Master of Arts in International Development Studies and a Bachelor’s degree in Management Information Systems \n  \nAbout the Global Health Coffee Sessions\nThe Global Health Coffee Sessions is a virtual series of timely conversations on wide-ranging topics at the intersection of health\, policy\, and global cooperation. The series brings together global health experts\, policymakers\, and practitioners from Harvard and beyond for dynamic\, forward-looking discussions. \nAll sessions are hosted virtually via Zoom\, recorded\, and available afterward on our YouTube Channel. \nThe Harvard Global Health Institute provides a platform for different perspectives and debates within the field of global health through a variety of media. The views expressed in these events and programs are solely those of the speakers\, authors\, researchers\, and participating audience. As such\, they do not speak for the institute or the university.
URL:https://globalhealth.harvard.edu/event/coffee-session-measuring-impact-is-ai-improving-health-outcomes/
LOCATION:Zoom\, Virtual: Zoom
CATEGORIES:Virtual
ATTACH;FMTTYPE=image/png:https://globalhealth.harvard.edu/wp-content/uploads/2026/04/April-24th-Coffee-Sessions-Promo-Image-900x600px.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20260512T120000
DTEND;TZID=UTC:20260512T124500
DTSTAMP:20260525T103325
CREATED:20260126T144252Z
LAST-MODIFIED:20260408T135653Z
UID:10001046-1778587200-1778589900@globalhealth.harvard.edu
SUMMARY:Addressing the Global Challenges of Drug-Resistant Gonorrhea
DESCRIPTION:Neisseria gonorrhoeae\, the cause of the sexually transmitted disease gonorrhea\, causes a high burden of disease and has become resistant to each of the first-line antibiotics used to treat it\, including increasing resistance to ceftriaxone\, the mainstay of treatment globally. With two new antibiotics recently approved for treatment\, the increasing use of doxycycline post-exposure prophylaxis for bacterial sexually transmitted infections\, and development of new diagnostics\, we have new tools to deploy. But how best to do so remains unclear. \nIn this presentation\, Professor Yonatan Grad will review recent advances in the diagnosis\, treatment\, and prevention of gonorrhea\, and discuss emerging frameworks for optimizing implementation and rollout strategies in diverse healthcare settings. \nThis webinar is free and open to the public and will include time for audience Q&A. \nRegister \n\nSpeaker\n \nYonatan Grad\, MD\, PhD\nProfessor of Immunology and Infectious Diseases and Director\, Center for Communicable Disease Dynamics\, Harvard T.H. Chan School of Public Health; Faculty\, Division of Infectious Diseases\, Brigham and Women’s Hospital \nYonatan is Professor of Immunology and Infectious Diseases and Director of the Center for Communicable Disease Dynamics at the Harvard T.H. Chan School of Public Health\, and faculty in the Division of Infectious Diseases at Brigham and Women’s Hospital. The Grad lab focuses on how to prepare and respond effectively to infectious disease threats through understanding interacting processes from microbial evolution through human ecology. The lab uses interdisciplinary methods\, including microbial genetics\, population genomics\, and mathematical modeling to move across these scales\, with goals of advancing clinical and public health practices. He works with public health institutions locally\, nationally\, and internationally\, including serving on WHO guideline committees for sexually transmitted infections. \n\n  \nGlobal Health Research and Innovation Speaker Series\nThe Harvard Global Health Institute’s Global Health Research and Innovation Speaker Series showcases the latest scholarly and scientific advancements in global health across Harvard and beyond\, to make cutting-edge research accessible to a diverse global audience\, and to spark innovative solutions in the pursuit of health equity and improved health outcomes worldwide. The public series takes place virtually on the second Tuesday of each month from 12:00 to 12:45 pm ET. Each session will include a presentation by a featured speaker showcasing their innovative research in global health\, followed by a moderated Q&A. \nThe Harvard Global Health Institute provides a platform for different perspectives and debates within the field of global health through a variety of media. The views expressed in these events and programs are solely those of the speakers\, authors\, researchers\, and participating audience. As such\, they do not speak for the institute or the university.
URL:https://globalhealth.harvard.edu/event/research-innovation-global-challenges-drug-resistant-gonorrhea/
LOCATION:Zoom\, Virtual: Zoom
CATEGORIES:Virtual
ATTACH;FMTTYPE=image/png:https://globalhealth.harvard.edu/wp-content/uploads/2026/01/Ruanne-Barnabas-RI-Speaker-Series-Promo-Image-900x600-25.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20260515T130000
DTEND;TZID=UTC:20260515T170000
DTSTAMP:20260525T103325
CREATED:20260330T143731Z
LAST-MODIFIED:20260513T174903Z
UID:10001054-1778850000-1778864400@globalhealth.harvard.edu
SUMMARY:Malaria in a Changing World: Past Lessons\, Present Challenges\, and Future Solutions
DESCRIPTION:Event Description\nMalaria is one of the oldest human diseases\, having sculpted human biological evolution and history in many regions. Yet it remains a heavy burden on global public health in today’s changing world\, where migration\, climate change\, and shifting mosquito vectors are influencing the global stage for this disease. New insights and innovative control methods\, however\, may help turn the tide against the scourge of malaria. \nThe program will feature expert talks\, panel discussions\, and Q&A sessions with leading researchers\, including special guest Dr. Fitsum Tadesse from the Armauer Hansen Research Institute in Ethiopia\, who will share insights on the challenges facing malaria control in the Horn of Africa. A reception will follow the symposium for light refreshments. \nThis symposium is part of the Environmental Pressures on Malaria Scholarly Working Group\, supported by the Harvard Global Health Institute\, and is co-sponsored by the Defeating Malaria: From the Genes to the Globe Initiative\, the Nigerian Student Association at Harvard Chan\, and the Harvard Undergraduate Premedical Society. \nPlease note: This event is in person and registration is required (space is limited).  \nRegister \nSpeakers\n\nCaroline Buckee\, PhD | Deputy Director\, Institute for Disease Modeling\, Gates Foundation; Professor of Epidemiology\,\nHarvard T.H. Chan School of Public Health\nFlaminia Catteruccia\, PhD | Irene Heinz Given Professor of Immunology and Infectious Diseases; Investigator\,\nHarvard T.H. Chan School of Public Health; Howard Hughes Medical Institute\nMarcia Castro\, PhD | Andelot Professor of Demography; Chair\, Department of Global Health and Population\,\nHarvard T.H. Chan School of Public Health\nManoj Duraisingh\, PhD | John LaPorte Given Professor of Immunology and Infectious Diseases\,\nHarvard T.H. Chan School of Public Health\nAzza Idris\, MD\, PhD | Assistant Professor of Pediatrics\, Harvard Medical School; Pediatrician\, Pediatric Infectious Disease\, Massachusetts General Hospital\nMegan Michel\, PhD | Postdoctoral Researcher\, Department of Human Evolutionary Biology\, Harvard University\nDaniel Neafsey\, PhD | Associate Professor of Immunology and Infectious Diseases\, Harvard T.H. Chan School of Public Health\nFitsum Tadesse\, PhD | Lead Scientist; Wellcome Trust Fellow (2023–2028)\, Armauer Hansen Research Institute (AHRI) Ethiopia\nDyann F. Wirth\, PhD | Richard Pearson Strong Professor of Infectious Diseases\, Harvard T.H. Chan School of Public Health
URL:https://globalhealth.harvard.edu/event/malaria-in-a-changing-world-symposium/
LOCATION:Richard A. and Susan F. Smith Campus Center\, 1350 Massachusetts Ave\, Cambridge\, MA\, MA\, 02138\, United States
CATEGORIES:In-person
ATTACH;FMTTYPE=image/png:https://globalhealth.harvard.edu/wp-content/uploads/2026/03/Malaria-in-a-Changing-World-Symposium-Promo-Image-900-x-600px-10.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20260529T090000
DTEND;TZID=UTC:20260529T100000
DTSTAMP:20260525T103325
CREATED:20260519T140207Z
LAST-MODIFIED:20260520T152557Z
UID:10001056-1780045200-1780048800@globalhealth.harvard.edu
SUMMARY:Can AI Transform Global Health? Promise\, Progress\, and Reality
DESCRIPTION:This session examines the state of AI in global health through a central question: with governments and donors now actively shaping AI policy for health\, how do we ensure the evidence base and frontline capacity keep pace with the speed of deployment\, and where does hype outpace the evidence? Speakers will explore persistent gaps in health systems\, from workforce shortages and delayed diagnostics to fragmented data systems and outbreak preparedness\, alongside the growing landscape of AI applications designed to address them. The discussion will critically examine recurring misalignments between donor priorities\, technology development\, and frontline health worker needs\, while also considering the practical realities that shape implementation. \nHosted by the Harvard Global Health Institute and co-organized by the Center for Bioethics at Harvard Medical School. \nThis webinar is free and open to the public and will conclude with a live Q&A session. \nRegister \n  \nSpeakers\n \nRose Nakasi\, PhD\nHead of the Makerere Artificial Intelligence Health Lab \nDr. Rose Nakasi\, an Artificial Intelligence Research Scientist and Lecturer at Makerere University\, is breaking new ground in health technology as the Head of the Makerere Artificial Intelligence Health Lab. She spearheads innovative projects like the Lacuna-funded initiative for Sexual Reproductive and Maternal Health and the Google-funded “Ocular” project\, focusing on AI-driven mobile microscopy diagnosis of Malaria\, Tuberculosis\, and cancer. Her dedication to healthcare is evident through her work with the NIH DS-I Africa consortium on the DS-I Malaria project in Uganda. With a PhD in Computer Science from Makerere University\, Rose is making significant strides in AI and health technology. Rose also leads the ITU/WHO/WIPO Topic Group on “AI based detection of Malaria” under the Global Initiative AI for Health (GIAI4H) and a committee member on the CODATA International Data Policy Committee. \n  \n \nSameer Pujari\nAI Lead\, Global Digital Health Strategy & Governance\, World Health Organization; Vice Chair\, ITU–WHO Focus Group on AI 4 Health \nSameer Pujari is currently leading  WHO AI for Health Programme and heads the WHO Secretariat for the Global Initiative on AI for Health\, a joint initiative with WHO\, ITU and WIPO where he is convening global AI labs\, leading development and deployment of standards\, policies\, and norms on AI for health\, building benchmarking and evaluation frameworks for verifiable AI in health\, and shaping AI readiness for WHO and its Member States.  He previously led the development and negotiations of the WHO Global Strategy on Digital Health across all 194 Member States. He has also served as Vice Chair of the WHO–ITU Focus Group on AI for Health. \nSameer joined WHO Headquarters in Geneva in February 2008. Over his career\, he has worked extensively on digital health — spanning mHealth\, big data\, and AI — and has established several global digital health initiatives. He has provided in-country support across 75+ countries in all WHO regions and has contributed to close to 100 publications\, guidance documents\, and reports on digital health and AI. He is a recipient of the WHO Director-General’s Award for Excellence (2016) and the Greenpeace Innovations Award (2018). \n  \nModerator\n \nMatthew Bonds\, PhD\nAssociate Professor of Global Health and Social Medicine at Harvard Medical School; Co-Founder & Scientific Director of PIVOT \nProfessor Matthew Bonds has a PhD in economics and a PhD in (disease) ecology from the University of Georgia. He is an associate professor of global health and social medicine at Harvard Medical School\, and co-founder & scientific director of PIVOT. His research focuses on 1) the ecology of poverty and economic development; and 2) the science of implementing global health delivery systems. PIVOT works with the Madagascar government to establish a district level model health system for over 200\,000 people. With novel data systems at all levels of care (community\, primary and secondary care)\, this partnership is pioneering a new science of health system transformation\, with some of the most rigorously evaluated population level impacts in the world. His work has been supported by a K01 Award from the NIH Fogarty International Center\, a Scholar Award in Complex Systems Science from the James S. McDonnell Foundation\, and a Rainer Arnhold Fellowship from the Mulago Foundation. \n  \nAbout the Global Health Coffee Sessions\nThe Global Health Coffee Sessions is a virtual series of timely conversations on wide-ranging topics at the intersection of health\, policy\, and global cooperation. The series brings together global health experts\, policymakers\, and practitioners from Harvard and beyond for dynamic\, forward-looking discussions. \nAll sessions are hosted virtually via Zoom\, recorded\, and available afterward on our YouTube Channel. \nThe Harvard Global Health Institute provides a platform for different perspectives and debates within the field of global health through a variety of media. The views expressed in these events and programs are solely those of the speakers\, authors\, researchers\, and participating audience. As such\, they do not speak for the institute or the university.
URL:https://globalhealth.harvard.edu/event/coffee-session-can-ai-transform-global-health/
LOCATION:Zoom\, Virtual: Zoom
CATEGORIES:Virtual
ATTACH;FMTTYPE=image/png:https://globalhealth.harvard.edu/wp-content/uploads/2026/05/April-24th-Coffee-Sessions-Promo-Image-900x600px-7.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20260609T120000
DTEND;TZID=UTC:20260609T124500
DTSTAMP:20260525T103325
CREATED:20260126T144414Z
LAST-MODIFIED:20260518T171052Z
UID:10001047-1781006400-1781009100@globalhealth.harvard.edu
SUMMARY:Combining Evidence from Observational Studies and Population Surveys to Better Predict Cardiovascular Disease Risk
DESCRIPTION:Cardiovascular diseases (CVD) remain the leading cause of death worldwide. Although CVD mortality declined substantially over the past five decades\, progress in the United States has slowed since 2010. Reviving these gains will require more effective implementation of prevention strategies\, including improved methods for identifying individuals at highest risk. \nIn this presentation\, Dr. Goodarz Danaei will discuss emerging approaches to cardiovascular risk prediction and prevention\, including the use of causal inference methods and nationally representative data to develop more accurate risk models. He will explore the limitations of existing prediction tools\, which often rely on outdated cohort studies or nonrepresentative electronic medical record data\, and present new research aimed at improving population-level prevention strategies in the United States and globally. \nThis webinar is free and open to the public and will include time for audience Q&A. \nRegister \n  \nSpeaker\n \nGoodarz Danaei\, MD\nBernard Lown Professor of Cardiovascular Health\, Global Health and Population\, Harvard T.H. Chan School of Public Health; Faculty Director\, Bernard Lown Scholars in Cardiovascular Health Program \nDr. Goodarz Danaei is the Bernard Lown Professor of Cardiovascular Health in the Department of Global Health and Population at the Harvard T.H. Chan School of Public Health. His global health research focuses on quantifying the population-level impact of risk factors and preventive interventions on cardiovascular disease\, globally with a focus on low- and middle-income countries. He led the team that developed the only country-level risk prediction model for cardiovascular disease (www.globorisk.org) that has since been used dozens of researchers and clinical groups worldwide. His epidemiological research applies advanced methods of causal inference to emulate the design and analysis of target trials using electronic health records and other observational data. As a member of CAUSALab\, he has helped develop and apply marginal Structural Models and the G-formula to quantify causal effects of lifestyle changes or medications on long-term risk of cardiovascular diseases. \n  \nGlobal Health Research and Innovation Speaker Series\nThe Harvard Global Health Institute’s Global Health Research and Innovation Speaker Series showcases the latest scholarly and scientific advancements in global health across Harvard and beyond\, to make cutting-edge research accessible to a diverse global audience\, and to spark innovative solutions in the pursuit of health equity and improved health outcomes worldwide. The public series takes place virtually on the second Tuesday of each month from 12:00 to 12:45 pm ET. Each session will include a presentation by a featured speaker showcasing their innovative research in global health\, followed by a moderated Q&A. \nThe Harvard Global Health Institute provides a platform for different perspectives and debates within the field of global health through a variety of media. The views expressed in these events and programs are solely those of the speakers\, authors\, researchers\, and participating audience. As such\, they do not speak for the institute or the university.
URL:https://globalhealth.harvard.edu/event/research-innovation-goodarz-danaei/
LOCATION:Zoom\, Virtual: Zoom
CATEGORIES:Virtual
ATTACH;FMTTYPE=image/png:https://globalhealth.harvard.edu/wp-content/uploads/2026/01/Ruanne-Barnabas-RI-Speaker-Series-Promo-Image-900x600-28.png
END:VEVENT
END:VCALENDAR